These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 29368550)
1. Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia. Li Q; Li R; Wall SB; Dunigan K; Ren C; Jilling T; Rogers LK; Tipple TE Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L736-L742. PubMed ID: 29368550 [TBL] [Abstract][Full Text] [Related]
2. Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation. Li Q; Wall SB; Ren C; Velten M; Hill CL; Locy ML; Rogers LK; Tipple TE Am J Respir Cell Mol Biol; 2016 Sep; 55(3):419-28. PubMed ID: 27089175 [TBL] [Abstract][Full Text] [Related]
3. Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury. Locy ML; Rogers LK; Prigge JR; Schmidt EE; Arnér ES; Tipple TE Antioxid Redox Signal; 2012 Nov; 17(10):1407-16. PubMed ID: 22607006 [TBL] [Abstract][Full Text] [Related]
4. Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice. Dunigan-Russell K; Lin V; Silverberg M; Wall SB; Li R; Gotham J; Nicola T; Sridharan A; Snowball J; Delaney C; Li Q; Tipple TE Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1165-L1171. PubMed ID: 32292070 [TBL] [Abstract][Full Text] [Related]
5. Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia. Wall SB; Wood R; Dunigan K; Li Q; Li R; Rogers LK; Tipple TE Oxid Med Cell Longev; 2019; 2019():7945983. PubMed ID: 30805084 [TBL] [Abstract][Full Text] [Related]
6. Quercetin attenuates the hyperoxic lung injury in neonatal mice: Implications for Bronchopulmonary dysplasia (BPD). Maturu P; Wei-Liang Y; Androutsopoulos VP; Jiang W; Wang L; Tsatsakis AM; Couroucli XI Food Chem Toxicol; 2018 Apr; 114():23-33. PubMed ID: 29432836 [TBL] [Abstract][Full Text] [Related]
7. The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms. Dunigan K; Li Q; Li R; Locy ML; Wall S; Tipple TE Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L545-L552. PubMed ID: 30024305 [TBL] [Abstract][Full Text] [Related]
8. Effects of hyperoxia exposure on the expression of Nrf2 and heme oxygenase-1 in lung tissues of premature rats. Chu X; Zhang X; Gong X; Zhou H; Cai C Mol Cell Probes; 2020 Jun; 51():101529. PubMed ID: 32036037 [TBL] [Abstract][Full Text] [Related]
9. Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice. Tamatam CM; Reddy NM; Potteti HR; Ankireddy A; Noone PM; Yamamoto M; Kensler TW; Reddy SP Sci Rep; 2020 Nov; 10(1):19034. PubMed ID: 33149211 [TBL] [Abstract][Full Text] [Related]
10. The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome. Britt RD; Velten M; Locy ML; Rogers LK; Tipple TE Antioxid Redox Signal; 2014 Jun; 20(17):2681-91. PubMed ID: 24295151 [TBL] [Abstract][Full Text] [Related]
12. Irisin alleviates hyperoxia-induced bronchopulmonary dysplasia through activation of Nrf2/HO-1 pathway. Zhao ZW; Lin XX; Guo YZ; He X; Zhang XT; Huang Y Peptides; 2023 Dec; 170():171109. PubMed ID: 37804931 [TBL] [Abstract][Full Text] [Related]
13. Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia. Rath P; Nardiello C; Surate Solaligue DE; Agius R; Mižíková I; Hühn S; Mayer K; Vadász I; Herold S; Runkel F; Seeger W; Morty RE Pediatr Res; 2017 May; 81(5):795-805. PubMed ID: 28141790 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Tipple TE; Welty SE; Nelin LD; Hansen JM; Rogers LK Am J Respir Cell Mol Biol; 2009 Nov; 41(5):612-9. PubMed ID: 19244202 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice. Cho HY; Miller-DeGraff L; Blankenship-Paris T; Wang X; Bell DA; Lih F; Deterding L; Panduri V; Morgan DL; Yamamoto M; Reddy AJ; Talalay P; Kleeberger SR Toxicol Appl Pharmacol; 2019 Feb; 364():29-44. PubMed ID: 30529165 [TBL] [Abstract][Full Text] [Related]
16. Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. McGrath-Morrow S; Lauer T; Yee M; Neptune E; Podowski M; Thimmulappa RK; O'Reilly M; Biswal S Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L565-73. PubMed ID: 19151108 [TBL] [Abstract][Full Text] [Related]
17. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Deng X; Rui W; Zhang F; Ding W Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA variation modulates alveolar development in newborn mice exposed to hyperoxia. Kandasamy J; Rezonzew G; Jilling T; Ballinger S; Ambalavanan N Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L740-L747. PubMed ID: 31432715 [TBL] [Abstract][Full Text] [Related]
19. Autophagy inducer activates Nrf2-ARE pathway to attenuate aberrant alveolarization in neonatal rats with bronchopulmonary dysplasia. Zhao X; Shi Y; Zhang D; Tong X; Sun Y; Xue X; Fu J Life Sci; 2020 Jul; 252():117662. PubMed ID: 32298739 [TBL] [Abstract][Full Text] [Related]
20. Sex-related differences in long-term pulmonary outcomes of neonatal hyperoxia in mice. Namba F; Ogawa R; Ito M; Watanabe T; Dennery PA; Tamura M Exp Lung Res; 2016; 42(2):57-65. PubMed ID: 27070483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]